🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Kovai Medical Center and Hospital Limited KOVAI NSEPHARMA

Healthcare · Medical Care Facilities · India
https://www.kmchhospitals.com

Kovai Medical Center and Hospital Limited operates a multi-speciality hospital primarily in India. The company operates in two segments, Healthcare Services and Education Services. It operates various medical facilities, which provide services related to emergency and trauma care, cardiology, oncology, gynaecology and obstetrics, radiology, transplant, neurology, as well as orthopaedics and joint replacement, gastroenterology and haematology, pediatrics, endocrinology, diabetes management, rheumatology, pulmonology, psychiatry, cosmetic surgery, ENT, dermatology, hematology, urology, nephrology, and paediatrics. The company also offers preventive health check-ups and wellbeing programs. In addition, it operates a medical college in Coimbatore. The company serves out-patients, in-patients, and common public. Kovai Medical Center and Hospital Limited was incorporated in 1985 and is based in Coimbatore, India.

READ MORE ›
₹5,360.50
-2.32% 1Y

Market & Price

Market Cap
₹5,865.60 Cr
Current Price
₹5,360.50
High / Low (52W)
₹5,955.40 / ₹5,339.00
Beta
0.49

Valuation

Stock P/E
23.98
Industry PE
37.60
Forward P/E
-
PEG Ratio
-
Book Value
₹1,205.74
Price to Book
4.45
P/S
3.70
EV/EBITDA
13.49
Dividend Yield
0.28%

Profitability & Returns

ROCE
20.57%
ROE
20.33%
ROA
10.65%
Profit Margin
15.42%
Op Margin
19.80%
EPS (Latest Qtr)
₹54.55
EPS (TTM)
₹223.53

Balance Sheet & Liquidity

Debt/Equity
0.31
Quick Ratio
1.20
Current Ratio
1.29
Debt
₹402.75 Cr
Total Assets
₹2,066.08 Cr
Current Assets
₹420.94 Cr
Working Capital
₹94.20 Cr

Ownership

Promoter Holding
58.02%
Chg in Prom Hold
-
FII / Inst Holding
3.49%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹5,920.74 Cr
Total Revenue (TTM)
₹1,585.64 Cr
EBITDA
₹438.86 Cr
Free Cash Flow
₹66.72 Cr
Operating Cash Flow
₹361.83 Cr
Shares Outstanding
₹1.09 Cr
Gross Margin
52.41%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
18.24%
Profit 5Y
28.29%
Revenue (YoY)
15.90%
Earnings (YoY)
9.10%

PROS

  • Strong return on equity of 20.3%.
  • Healthy ROCE of 20.6%.
  • Compounding revenue at 18.2% over 5 years.
  • Profit CAGR of 28.3% over 5 years.
  • Generates positive free cash flow.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 KOVAI Kovai Medical Center and Hospital Limited NSEPHARMA 5,360.50 23.98 ₹5,865.60 Cr 0.28% 20.57% 20.33% 18.24% 28.29%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -354.70 Cr356.64 Cr373.59 Cr390.74 Cr406.62 Cr413.20 Cr
Cost of Revenue -141.43 Cr150.83 Cr151.07 Cr161.50 Cr159.32 Cr173.76 Cr
Gross Profit -213.27 Cr205.81 Cr222.52 Cr229.24 Cr247.30 Cr239.44 Cr
Operating Expenses -134.99 Cr129.27 Cr142.64 Cr149.02 Cr158.95 Cr157.53 Cr
Operating Income -78.28 Cr76.54 Cr79.88 Cr80.22 Cr88.35 Cr81.91 Cr
EBITDA -108.91 Cr107.48 Cr111.49 Cr113.41 Cr123.16 Cr119.05 Cr
Interest Expense -9.16 Cr8.65 Cr9.17 Cr8.74 Cr8.42 Cr5.68 Cr
Pretax Income -75.13 Cr74.32 Cr76.38 Cr77.89 Cr87.14 Cr84.28 Cr
Tax Provision -17.33 Cr19.62 Cr19.16 Cr19.03 Cr22.12 Cr24.59 Cr
Net Income -57.80 Cr54.70 Cr57.23 Cr58.86 Cr65.02 Cr59.69 Cr
Diluted EPS 46.3252.8349.9952.3053.7959.4254.55

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -958.19 Cr1,133.84 Cr1,369.74 Cr1,584.15 Cr
Cost of Revenue -458.44 Cr528.43 Cr587.38 Cr669.19 Cr
Gross Profit -499.74 Cr605.41 Cr782.36 Cr914.96 Cr
Operating Expenses -316.23 Cr353.05 Cr494.23 Cr585.50 Cr
Operating Income -183.51 Cr252.36 Cr288.13 Cr329.46 Cr
EBITDA -284.32 Cr362.48 Cr407.82 Cr467.10 Cr
Interest Expense -39.97 Cr32.78 Cr32.68 Cr32.02 Cr
Pretax Income -155.22 Cr237.56 Cr277.55 Cr325.69 Cr
Tax Provision -39.45 Cr57.83 Cr68.61 Cr81.23 Cr
Net Income -115.77 Cr179.73 Cr208.95 Cr244.46 Cr
Diluted EPS --164.25190.95-

Compounded Sales Growth

5 Years:18.24%
1 Year:15.90%

Compounded Profit Growth

5 Years:28.29%
1 Year:9.10%

Stock Price Performance

1 Year:-2.32%
6 Months:-
3 Months:-
1 Month:-5.85%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -1,438.12 Cr1,438.23 Cr1,799.91 Cr2,066.08 Cr
Current Assets -295.05 Cr250.41 Cr330.51 Cr420.94 Cr
Cash & Equivalents -17.95 Cr59.60 Cr14.30 Cr63.72 Cr
Inventory -13.72 Cr14.70 Cr15.62 Cr20.25 Cr
Receivables -16.72 Cr12.52 Cr23.77 Cr38.08 Cr
Total Liabilities -719.08 Cr549.70 Cr713.75 Cr746.82 Cr
Current Liabilities -181.16 Cr203.13 Cr269.86 Cr326.74 Cr
Long Term Debt -447.37 Cr253.18 Cr348.33 Cr317.35 Cr
Total Debt -510.91 Cr310.36 Cr415.34 Cr402.75 Cr
Total Equity -719.04 Cr888.54 Cr1,086.16 Cr1,319.27 Cr
Shares Outstanding -1.09 Cr1.09 Cr1.09 Cr1.09 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -262.91 Cr344.13 Cr352.91 Cr361.83 Cr
Investing Cash Flow --126.86 Cr-138.17 Cr-352.14 Cr-230.18 Cr
Financing Cash Flow --85.70 Cr-243.49 Cr62.09 Cr-58.37 Cr
Capital Expenditure --127.40 Cr-138.42 Cr-353.10 Cr-251.95 Cr
Free Cash Flow -135.52 Cr205.71 Cr-18.47 L109.88 Cr
Net Change in Cash -50.35 Cr-37.53 Cr62.87 Cr73.28 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -52.2%53.4%57.1%57.8%
Operating Margin % -19.2%22.3%21.0%20.8%
Net Margin % -12.1%15.9%15.3%15.4%
ROE % -16.1%20.2%19.2%18.5%
ROCE % -14.6%20.4%18.8%18.9%

Shareholding Pattern

Insiders
58.02%
Institutions
3.49%
Public Float
8.32%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KOVAI

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space